Hormone Therapy and Young-Onset Breast Cancer

Estrogen plus progestin hormone therapy (HT) is associated with an increased risk of postmenopausal breast cancer, but few studies have examined the impact of HT use on the risk of breast cancer in younger women. We assessed the association between estrogen plus progestin HT or unopposed estrogen HT...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Am J Epidemiol
Prif Awduron: O'Brien, Katie M., Fei, Chunyuan, Sandler, Dale P., Nichols, Hazel B., DeRoo, Lisa A., Weinberg, Clarice R.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2015
Pynciau:
Original Contributions
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4423525/
https://ncbi.nlm.nih.gov/pubmed/25698646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/aje/kwu347
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg